Connect with us

Business

Remdesivir approved by FDA to treat Covid-19, but the evidence is mixed – Vox.com

Scientists are concerned the FDA’s first full approval of a Covid-19 drug doesn’t have enough research behind it.

Published

on

post featured image
ADVERTISEMENT

The Food and Drug Administration on Thursday gave itsfirst full approval for a drug to treat Covid-19 to the antiviral remdesivir. But some researchers say the FDA is once again promoting a Covid-19 therapy based on shaky evidence.
Developed by Gilead Sciences and marketed under the brand name Veklury, remdesivir previously received emergency use authorization (EUA) from the FDA in May, which allowed it to be used to treat patients with severe Covid-19. In August, the FDA relaxed its guidelines…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
A 19-Year Veteran of the Butterball Turkey Talk Line on How Callers Have Changed This Year – Slate
post featured image
AstraZeneca manufacturing error clouds vaccine study results – The Associated Press
post featured image
Tesla increases prices on next EU batch of Model S and Model X —sparking refresh rumors – Electrek